Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Medicamen Biotech Ltd

NSE: MEDICAMEQ · BSE: 531146 · Pharmaceuticals & Biotechnology · 14 announcements

Share price
₹313.25
Market cap
₹424.9 Cr
Revenue (annual)
₹197.8 Cr
Net profit (annual)
₹9.64 Cr
P/E (TTM)
39.2×Sector 47.3×
Promoter holding
40.46%+0.00% QoQ
FII holding
0.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:57 IST BSE
Board Meeting Date

Medicamen Biotech Board Meeting Date

Medicamen Biotech Limited has scheduled a board meeting for August 14, 2026. The board will consider unaudited financial results for the quarter ended June 30, 2026.

15:59 IST BSE
Board Meeting Date

Medicamen Biotech Board Meeting Date

Medicamen Biotech scheduled a board meeting for May 27, 2026. Directors will consider FY26 audited financial results and recommend a final dividend for the year.